Skip to main content

. 1975 Jun 21;2(5972):651–652. doi: 10.1136/bmj.2.5972.651-a

Oestrogenic potency and oral contraceptives.

PMCID: PMC1673585 PMID: 1169999

651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Brown J. B., Blair H. A. Urinary OEstrogen Metabolites of 19-Norethisterone and its Esters [Summary]. Proc R Soc Med. 1960 Jun;53(6):433–433. doi: 10.1177/003591576005300611. [DOI] [PMC free article] [PubMed] [Google Scholar]
Inman W. H., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J. 1970 Apr 25;2(5703):203–209. doi: 10.1136/bmj.2.5703.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rooks W. H., 2nd, Kugler S. L., Dorfman R. I. The relative expressed estrogenicity of oral contraceptives. Fertil Steril. 1968 May-Jun;19(3):419–423. doi: 10.1016/s0015-0282(16)36671-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES